Get Fluorouracil 5% cream onto the PBS
Get Fluorouracil 5% cream onto the PBS
Recent signers:
Peter Buchtmann and 19 others have signed recently.
The issue
Two out of three Australians will develop skin cancer at some point in their life. It's a startling statistic that underscores a national health crisis. Skin cancer is so common that it's easy to become desensitized to this silent threat. Yet behind these numbers are real people, each facing the devastating reality of a cancer diagnosis.
For many, Fluorouracil 5% cream is a lifeline. This topical chemotherapy treatment is often prescribed to treat actinic keratosis and non-melanoma skin cancer. While effective, the cream comes with significant financial burdens for patients who need it most. Currently, Fluorouracil 5% cream is not covered by the Pharmaceutical Benefits Scheme (PBS) in Australia for either general or concession patients. This leaves individuals with no choice but to struggle with the costs at a time when they are already feeling vulnerable and overwhelmed.
Most patients prescribed Fluorouracil 5% cream are also managing multiple other health conditions, often taking five or more prescription medications. The financial strain is especially significant for the elderly or those already battling other diseases. It's unjust that they face the added stress of unaffordable medication at such a critical time in their lives.
Including Fluorouracil 5% cream onto the PBS would alleviate this undue financial burden and would be a major step forward in providing equitable healthcare for all Australians. It ensures that every individual, regardless of their financial situation, will have access to necessary and life-saving treatment.
We call upon the Australian Government and the PBS Advisory Committee to urgently review this matter. Our healthcare system should support patients in their fight against cancer, not make the journey harder.
If this issue resonates with you or someone you know, please sign this petition. Your signature could be the one that influences a change, making Fluorouracil 5% cream accessible to all who need it. Let's make cancer treatment more affordable and offer hope and support to those who need it most. Sign now and be part of this vital change.
For many, Fluorouracil 5% cream is a lifeline. This topical chemotherapy treatment is often prescribed to treat actinic keratosis and non-melanoma skin cancer. While effective, the cream comes with significant financial burdens for patients who need it most. Currently, Fluorouracil 5% cream is not covered by the Pharmaceutical Benefits Scheme (PBS) in Australia for either general or concession patients. This leaves individuals with no choice but to struggle with the costs at a time when they are already feeling vulnerable and overwhelmed.
Most patients prescribed Fluorouracil 5% cream are also managing multiple other health conditions, often taking five or more prescription medications. The financial strain is especially significant for the elderly or those already battling other diseases. It's unjust that they face the added stress of unaffordable medication at such a critical time in their lives.
Including Fluorouracil 5% cream onto the PBS would alleviate this undue financial burden and would be a major step forward in providing equitable healthcare for all Australians. It ensures that every individual, regardless of their financial situation, will have access to necessary and life-saving treatment.
We call upon the Australian Government and the PBS Advisory Committee to urgently review this matter. Our healthcare system should support patients in their fight against cancer, not make the journey harder.
If this issue resonates with you or someone you know, please sign this petition. Your signature could be the one that influences a change, making Fluorouracil 5% cream accessible to all who need it. Let's make cancer treatment more affordable and offer hope and support to those who need it most. Sign now and be part of this vital change.
Chris BillingsPetition starter
47
Recent signers:
Peter Buchtmann and 19 others have signed recently.
The issue
Two out of three Australians will develop skin cancer at some point in their life. It's a startling statistic that underscores a national health crisis. Skin cancer is so common that it's easy to become desensitized to this silent threat. Yet behind these numbers are real people, each facing the devastating reality of a cancer diagnosis.
For many, Fluorouracil 5% cream is a lifeline. This topical chemotherapy treatment is often prescribed to treat actinic keratosis and non-melanoma skin cancer. While effective, the cream comes with significant financial burdens for patients who need it most. Currently, Fluorouracil 5% cream is not covered by the Pharmaceutical Benefits Scheme (PBS) in Australia for either general or concession patients. This leaves individuals with no choice but to struggle with the costs at a time when they are already feeling vulnerable and overwhelmed.
Most patients prescribed Fluorouracil 5% cream are also managing multiple other health conditions, often taking five or more prescription medications. The financial strain is especially significant for the elderly or those already battling other diseases. It's unjust that they face the added stress of unaffordable medication at such a critical time in their lives.
Including Fluorouracil 5% cream onto the PBS would alleviate this undue financial burden and would be a major step forward in providing equitable healthcare for all Australians. It ensures that every individual, regardless of their financial situation, will have access to necessary and life-saving treatment.
We call upon the Australian Government and the PBS Advisory Committee to urgently review this matter. Our healthcare system should support patients in their fight against cancer, not make the journey harder.
If this issue resonates with you or someone you know, please sign this petition. Your signature could be the one that influences a change, making Fluorouracil 5% cream accessible to all who need it. Let's make cancer treatment more affordable and offer hope and support to those who need it most. Sign now and be part of this vital change.
For many, Fluorouracil 5% cream is a lifeline. This topical chemotherapy treatment is often prescribed to treat actinic keratosis and non-melanoma skin cancer. While effective, the cream comes with significant financial burdens for patients who need it most. Currently, Fluorouracil 5% cream is not covered by the Pharmaceutical Benefits Scheme (PBS) in Australia for either general or concession patients. This leaves individuals with no choice but to struggle with the costs at a time when they are already feeling vulnerable and overwhelmed.
Most patients prescribed Fluorouracil 5% cream are also managing multiple other health conditions, often taking five or more prescription medications. The financial strain is especially significant for the elderly or those already battling other diseases. It's unjust that they face the added stress of unaffordable medication at such a critical time in their lives.
Including Fluorouracil 5% cream onto the PBS would alleviate this undue financial burden and would be a major step forward in providing equitable healthcare for all Australians. It ensures that every individual, regardless of their financial situation, will have access to necessary and life-saving treatment.
We call upon the Australian Government and the PBS Advisory Committee to urgently review this matter. Our healthcare system should support patients in their fight against cancer, not make the journey harder.
If this issue resonates with you or someone you know, please sign this petition. Your signature could be the one that influences a change, making Fluorouracil 5% cream accessible to all who need it. Let's make cancer treatment more affordable and offer hope and support to those who need it most. Sign now and be part of this vital change.
Chris BillingsPetition starter
Support now
47
The Decision Makers
PBS Advisory Committee
Supporter voices
Petition Updates
Share this petition
Petition created on 15 January 2026